| Quarterly Financials | Jun 2019 | Sept 2019 | Dec 2019 | Mar 2020 | Jun 2020 | Sept 2020 | Dec 2020 | Mar 2021 | Jun 2021 | Sept 2021 | Dec 2021 | Mar 2022 | Jun 2022 | Sept 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sept 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sept 2024 | Dec 2024 | Mar 2025 |
Revenue  | 270 | 285 | 278 | 275 | 276 | 691 | 835 | 831 | 1,026 | 1,050 | 1,023 | 964 | 1,098 | 1,163 | 1,186 | 1,255 | 1,326 | 1,409 | 1,381 | 1,468 | 1,578 | 1,748 | 1,902 | 1,957 |
| Expenses | 239 | 253 | 245 | 228 | 514 | 564 | 636 | 634 | 756 | 787 | 729 | 729 | 802 | 818 | 828 | 874 | 948 | 976 | 949 | 1,041 | 1,156 | 1,257 | 1,443 | 1,398 |
| EBITDA | 31 | 31 | 32 | 47 | -239 | 127 | 200 | 197 | 270 | 262 | 293 | 235 | 296 | 345 | 359 | 381 | 379 | 433 | 432 | 427 | 422 | 491 | 459 | 559 |
| Operating Profit % | 9 % | 10 % | 8 % | 8 % | -101 % | 13 % | 20 % | 21 % | 24 % | 23 % | 25 % | 22 % | 25 % | 28 % | 28 % | 28 % | 26 % | 28 % | 29 % | 27 % | 25 % | 26 % | 23 % | 27 % |
| Depreciation | 12 | 11 | 11 | 12 | 26 | 52 | 48 | 48 | 54 | 54 | 55 | 58 | 57 | 58 | 57 | 60 | 56 | 58 | 61 | 70 | 77 | 84 | 98 | 101 |
| Interest | 10 | 21 | 27 | 25 | 35 | 53 | 46 | 45 | 27 | 27 | 25 | 22 | 22 | 22 | 20 | 20 | 19 | 9 | 11 | 21 | 24 | 34 | 52 | 55 |
| Profit Before Tax | 9 | -0 | -6 | 10 | -300 | 22 | 105 | 105 | 190 | 182 | 213 | 154 | 216 | 265 | 281 | 301 | 304 | 366 | 360 | 336 | 321 | 374 | 309 | 403 |
| Tax | -0 | 1 | -4 | -43 | 14 | 6 | 15 | 35 | 43 | 37 | 23 | 31 | 44 | -192 | 59 | 50 | 63 | 90 | 70 | 84 | 85 | 92 | 70 | 84 |
| Net Profit | 9 | -1 | -2 | 53 | -314 | 17 | 90 | 70 | 147 | 145 | 190 | 124 | 173 | 457 | 222 | 251 | 240 | 277 | 289 | 252 | 236 | 282 | 239 | 319 |
| EPS in ₹ | 0.17 | -0.03 | -0.03 | 0.91 | -4.34 | 0.18 | 1.00 | 0.76 | 1.52 | 1.50 | 1.96 | 1.28 | 1.78 | 4.72 | 2.29 | 2.58 | 2.47 | 2.85 | 2.98 | 2.59 | 2.43 | 2.90 | 2.46 | 3.28 |
Max Healthcare Institute
1,232.80
+30.60
(2.55%)
Market Cap
1,19,845.67 Cr
EPS
10.89
PE Ratio
103.24
Dividend Yield
0.12 %
Industry
Healthcare Services52 Week High
1,227.95
52 Week Low
836.60
PB Ratio
12.45
Debt to Equity
0.13
Sector
Hospitals
Investment Returns
In Long Term
In Short Term
1 Year
0.00%
2 Years
0.00%
3 Years
0.00%
4 Years
0.00%
5 Years
0.00%
Analyst Rating
- By Refinitiv from20 analysts
Peer Comparison Compare Peers on Screener
Competitors | LTP | Market Cap (₹ Cr.) | P/E Ratio | Revenue (₹ Cr.) | YoY Revenue Growth % | Net Profit (₹ Cr.) | YoY Profit Growth % | RSI |
|---|---|---|---|---|---|---|---|---|
1,232.80 | #1 1,19,845.67 | #10 103.24 | #3 5,584.10 | #4 18.77 | #1 1,058 | #4 26.84 | 65.57 | |
6,994.50 | 1,00,570.18 | 69.56 | #1 19,165.50 | 14.74 | 917 | 60.41 | 54.94 | |
754.00 | 56,923.84 | 67.72 | 6,931.20 | 8.99 | 645 | -7.43 | 61.43 | |
1,913.00 | 39,094.22 | 46.72 | 5,093.40 | 10.96 | 790 | 3.41 | 72.28 | |
1,186.00 | 31,854.46 | 61.36 | 2,759.20 | #1 25.09 | 326 | -20.35 | 44.55 | |
569.70 | 28,457.26 | 78.83 | 3,723.70 | 22.85 | 205 | #1 3,986.36 | 56.74 | |
679.95 | 27,207.45 | 70.28 | 2,511.20 | 12.94 | 336 | 48.39 | 57.38 | |
5,937.00 | 15,069.17 | #1 31.30 | 599.90 | 11.69 | 58 | 4.79 | 50.22 | |
1,421.60 | 14,436.59 | 60.78 | 1,334.00 | 10.76 | 218 | 10.57 | 54.41 | |
1,524.30 | 9,994.23 | 52.12 | 1,095.50 | 21.32 | 177 | -0.88 | 59.97 |
Forecast
Actual
Growth Rate
Revenue Growth
18.77 %
Net Income Growth
-4.16 %
Cash Flow Change
-12.64 %
ROE
-15.51 %
ROCE
4.66 %
EBITDA Margin (Avg.)
1.91 %
Quarterly Financial Results
Balance Sheet
| Balance Sheet | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
| Total Assets | 1,453 | 2,217 | 3,160 | 3,314 | 3,366 | 3,824 | 8,544 | 9,189 | 10,102 | 12,000 |
| Fixed Assets | 740 | 1,478 | 2,244 | 2,227 | 2,192 | 2,380 | 6,536 | 7,018 | 7,039 | 8,784 |
| Current Assets | 383 | 289 | 349 | 454 | 447 | 768 | 1,125 | 1,000 | 1,943 | 1,706 |
| Capital Work in Progress | 18 | 12 | 46 | 38 | 87 | 6 | 27 | 151 | 252 | 553 |
| Investments | 143 | 0 | 0 | 0 | 1 | 1 | 1 | 1 | 1 | 2 |
| Other Assets | 552 | 728 | 870 | 1,049 | 1,086 | 1,439 | 1,981 | 2,020 | 2,810 | 2,661 |
| Total Liabilities | 1,453 | 2,217 | 3,160 | 3,314 | 3,366 | 3,824 | 8,544 | 9,189 | 10,102 | 12,000 |
| Current Liabilities | 282 | 419 | 381 | 477 | 1,140 | 1,474 | 777 | 757 | 1,046 | 1,249 |
| Non Current Liabilities | 339 | 672 | 1,660 | 1,806 | 1,262 | 1,363 | 2,129 | 2,149 | 1,647 | 2,343 |
| Total Equity | 832 | 1,127 | 1,119 | 1,031 | 963 | 987 | 5,639 | 6,283 | 7,410 | 8,408 |
| Reserve & Surplus | 343 | 587 | 655 | 627 | 426 | 450 | 4,673 | 5,313 | 6,439 | 7,436 |
| Share Capital | 489 | 533 | 537 | 537 | 537 | 537 | 966 | 970 | 971 | 972 |
Cash Flow
| Cash Flow | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
| Net Cash Flow | 16 | -40 | 4 | -6 | -2 | 267 | 516 | -318 | 893 | -395 |
| Investing Activities | -194 | -364 | -104 | -124 | -17 | -127 | 206 | -764 | -102 | -1,253 |
| Operating Activities | 64 | 53 | 156 | 166 | 89 | 250 | 118 | 741 | 1,284 | 1,122 |
| Financing Activities | 145 | 271 | -48 | -48 | -74 | 144 | 191 | -294 | -289 | -264 |
Share Holding
| % Holding | Mar 2021 | Jun 2021 | Sept 2021 | Dec 2021 | Mar 2022 | Jun 2022 | Sept 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sept 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sept 2024 | Dec 2024 | Mar 2025 |
| Promoter | 70.46 % | 70.46 % | 60.91 % | 60.68 % | 50.64 % | 50.64 % | 23.80 % | 23.78 % | 23.77 % | 23.76 % | 23.76 % | 23.75 % | 23.75 % | 23.74 % | 23.74 % | 23.74 % | 23.74 % |
| FIIs | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.01 % | 0.01 % | 0.01 % | 0.00 % | 0.01 % | 0.01 % | 57.33 % | 56.98 % | 57.29 % | 56.93 % | 54.74 % |
| DIIs | 4.86 % | 7.93 % | 8.70 % | 15.60 % | 17.49 % | 19.26 % | 21.00 % | 20.47 % | 19.35 % | 11.90 % | 11.32 % | 11.34 % | 14.96 % | 15.36 % | 15.14 % | 15.55 % | 17.58 % |
| Government | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % |
| Public / Retail | 5.18 % | 5.76 % | 5.20 % | 5.23 % | 5.41 % | 4.94 % | 4.54 % | 4.36 % | 3.72 % | 3.54 % | 3.55 % | 3.34 % | 3.29 % | 3.24 % | 3.18 % | 3.13 % | 3.31 % |
| Others | 19.50 % | 15.84 % | 25.18 % | 18.49 % | 26.46 % | 25.16 % | 50.65 % | 51.38 % | 53.15 % | 60.80 % | 61.36 % | 61.56 % | 0.67 % | 0.67 % | 0.65 % | 0.64 % | 0.63 % |
| No of Share Holders | 45,339 | 70,655 | 91,937 | 1,11,877 | 1,20,079 | 1,05,000 | 1,01,659 | 1,11,701 | 1,04,656 | 1,11,374 | 1,18,635 | 1,11,338 | 1,27,009 | 1,36,254 | 1,37,856 | 1,40,028 | 1,51,633 |
Dividend History
Dividends per share (FY)
Dividend yield (FY) %
Dividends per share (FY)
Dividend yield (FY) %
| Annual Cash Flows | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Dividend Per Share (₹) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 1 | 1.5 | 0.00 |
| Dividend Yield (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.12 | 0.14 | 0.00 |
Corporate Action
| Record Date | Corporate Action | Information | Announcement Day | LTP at Annoucement | LTP at Record Day |
|---|---|---|---|---|---|
| 20 May 2025 |  Quarterly Result Announcement | NA | 20 May 2025 | 1,159.90 | 1,187.10 |
| 30 Jan 2025 | Quarterly Result Announcement | NA | 30 Jan 2025 | 1,082.95 | 1,025.90 |
| 05 Nov 2024 | Quarterly Result Announcement | NA | 05 Nov 2024 | 994.50 | 1,036.60 |
| 20 Sept 2024 |  Annual General Meeting | NA | 20 Sept 2024 | 882.75 | 984.55 |
| 23 Aug 2024 |  Dividend | ₹ 1.50 /share | 23 Aug 2024 | 835.15 | 869.30 |
| 27 Sept 2023 | Annual General Meeting | NA | 27 Sept 2023 | 553.60 | 566.10 |
| 08 Sept 2023 | Dividend | ₹ 1.00 /share | 08 Sept 2023 | 519.90 | 602.65 |
Announcements
Announcement under Regulation 30 (LODR)-Investor Presentation
May 31, 2025
May 31, 2025Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationMay 27, 2025
May 27, 2025Announcement under Regulation 30 (LODR)-Earnings Call TranscriptMay 27, 2025
May 27, 2025Compliances-Reg.24(A)-Annual Secretarial ComplianceMay 23, 2025
May 23, 2025Announcement under Regulation 30 (LODR)-Newspaper PublicationMay 21, 2025
May 21, 2025Audio Recording Of Earnings Call Held On May 21 2025May 21, 2025
May 21, 2025Appointment Of Secretarial Auditor And Cost AuditorMay 20, 2025
May 20, 2025Announcement under Regulation 30 (LODR)-Appointment of Statutory Auditor/sMay 20, 2025
May 20, 2025Presentation On Earnings UpdateMay 20, 2025
May 20, 2025Results For Quarter And Financial Year Ended March 31 2025May 20, 2025
May 20, 2025Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseMay 20, 2025
May 20, 2025Board Meeting Outcome for Meeting Held On May 20 2025May 20, 2025
May 20, 2025Execution Of Sale Deed For Acquisition Of Land And Building Situated In Uttar Pradesh By Crosslay Remedies LimitedMay 16, 2025
May 16, 2025Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationMay 13, 2025
May 13, 2025Board Meeting Intimation for Financial Results And Recommendation Of Final DividendMay 13, 2025
May 13, 2025Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPSMay 11, 2025
May 11, 2025Rumour verification - Regulation 30(11)May 06, 2025
May 06, 2025Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Apr 07, 2025
Apr 07, 2025Announcement under Regulation 30 (LODR)-Credit RatingApr 01, 2025
Apr 01, 2025Closure of Trading WindowMar 26, 2025
Mar 26, 2025Disclosure Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015Mar 22, 2025
Mar 22, 2025Disclosure Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015Mar 14, 2025
Mar 14, 2025Outcome Of Board MeetingMar 12, 2025
Mar 12, 2025Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationFeb 27, 2025
Feb 27, 2025Approval Of Scheme Of Amalgamation Between ALPS Hospital Limited And Max Hospitals And Allied Services LimitedFeb 26, 2025
Feb 26, 2025Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationFeb 24, 2025
Feb 24, 2025Announcement under Regulation 30 (LODR)-Change in ManagementFeb 18, 2025
Feb 18, 2025Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationFeb 14, 2025
Feb 14, 2025Announcement under Regulation 30 (LODR)-Investor PresentationFeb 11, 2025
Feb 11, 2025Announcement under Regulation 30 (LODR)-Earnings Call TranscriptFeb 06, 2025
Feb 06, 2025Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationFeb 03, 2025
Feb 03, 2025Announcement under Regulation 30 (LODR)-Updates on AcquisitionJan 31, 2025
Jan 31, 2025Announcement under Regulation 30 (LODR)-Newspaper PublicationJan 31, 2025
Jan 31, 2025Audio Recording Of Earnings Call Held On January 31 2025Jan 31, 2025
Jan 31, 2025Integrated Filing (Financial)Jan 30, 2025
Jan 30, 2025Agreement To Lease For Setting Up ~500 Bedded Build-To-Suit Hospital At Thane MaharashtraJan 30, 2025
Jan 30, 2025Presentation On Earnings UpdateJan 30, 2025
Jan 30, 2025Announcement under Regulation 30 (LODR)-AcquisitionJan 30, 2025
Jan 30, 2025Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseJan 30, 2025
Jan 30, 2025Board Meeting Outcome for Meeting Held On January 30 2025Jan 30, 2025
Jan 30, 2025Results- Financial Results For Quarter And Nine Months Ended December 31 2024Jan 30, 2025
Jan 30, 2025Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPSJan 29, 2025
Jan 29, 2025Grant Of Options Under Max Healthcare Institute Limited - Employee Stock Option Scheme 2022Jan 29, 2025
Jan 29, 2025Announcement under Regulation 30 (LODR)-Updates on AcquisitionJan 27, 2025
Jan 27, 2025Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationJan 24, 2025
Jan 24, 2025Board Meeting Intimation for Consideration And Approval Of Financial ResultsJan 24, 2025
Jan 24, 2025Disclosure Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015Jan 23, 2025
Jan 23, 2025Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Jan 08, 2025
Jan 08, 2025Change Of Name Of Registrar And Share Transfer AgentJan 01, 2025
Jan 01, 2025Closure of Trading WindowDec 27, 2024
Dec 27, 2024Technical Indicators
RSI(14)
Neutral 65.57
ATR(14)
Volatile 35.28
STOCH(9,6)
Overbought 83.08
STOCH RSI(14)
Overbought 94.83
MACD(12,26)
Bullish 5.72
ADX(14)
Weak Trend 14.76
UO(9)
Bearish 61.05
ROC(12)
Uptrend And Accelerating 7.29
WillR(14)
Overbought -5.66
Mutual Fund Holdings
| Funding House | No of Shares | Current Holding % | 1M Change % | 3M Change % | Month | |
|---|---|---|---|---|---|---|
 HDFC Mid-Cap Opportunities Fund Direct-Growth | 0 | 0.00% | -0.59% | -1.68% | May 2025 | |
 Kotak Equity Arbitrage Fund Direct-Growth | 3942750 | 0.66% | -0.27% | 0.28% | May 2025 | |
 SBI Equity Hybrid Fund Direct Plan-Growth | 7000000 | 1.04% | -0.13% | -0.15% | May 2025 | |
 Invesco India Arbitrage Fund Direct-Growth | 585900 | 0.30% | -0.32% | -0.01% | May 2025 | |
 Tata Balanced Advantage Fund Direct - Growth | 397000 | 0.44% | 0.44% | 0.44% | May 2025 | |
 Edelweiss Mid Cap Direct Plan-Growth | 2981836 | 3.35% | 0.17% | -0.05% | May 2025 | |
| SBI Arbitrage Opportunities Fund Direct-Growth | 727650 | 0.24% | -0.10% | -0.07% | May 2025 | |
| HDFC Arbitrage Fund Wholesale Direct-Growth | 1254750 | 0.68% | 0.11% | 0.34% | May 2025 | |
 Baroda BNP Paribas Multi Cap Fund Direct-Growth | 250000 | 0.99% | -0.84% | -0.90% | May 2025 | |
 Canara Robeco Emerging Equities Fund Direct-Growth | 4499645 | 2.02% | -0.10% | -0.18% | May 2025 | |
 ICICI Prudential Equity Arbitrage Direct-Growth | 350175 | 0.14% | 0.05% | 0.07% | May 2025 | |
| Tata Midcap Growth Direct Plan-Growth | 816000 | 1.95% | 0.24% | 0.18% | May 2025 | |
 WhiteOak Capital Mid Cap Fund Direct - Growth | 696537 | 2.46% | -0.60% | -0.79% | May 2025 | |
| Kotak Debt Hybrid Fund Direct -Growth | 112500 | 0.40% | 0.40% | 0.40% | May 2025 | |
 Mirae Asset Arbitrage Fund Direct - Growth | 59850 | 0.20% | -0.38% | -0.36% | May 2025 | |
| Tata Arbitrage Fund Direct - Growth | 571725 | 0.43% | -0.11% | 0.14% | May 2025 | |
 TRUSTMF Flexi Cap Fund Direct - Growth | 92566 | 0.94% | 0.94% | 0.94% | May 2025 | |
 Mahindra Manulife Multi Cap Fund Direct - Growth | 539000 | 1.12% | 0.15% | 0.46% | May 2025 | |
 HSBC Large and Mid Cap Fund Direct - Growth | 1231700 | 3.32% | 0.10% | -0.01% | May 2025 | |
| Edelweiss Large & Mid Cap Direct Plan-Growth | 780042 | 2.24% | 0.18% | 0.11% | May 2025 | |
 Bandhan Large Cap Fund Direct-Growth | 0 | 0.00% | -0.48% | -0.48% | May 2025 | |
 Aditya Birla Sun Life Pharma & Healthcare Fund Direct-Growth | 70000 | 0.97% | 0.97% | 0.97% | May 2025 | |
 UTI Healthcare Fund Direct-Growth | 251968 | 2.67% | 0.65% | 0.66% | May 2025 | |
| HSBC Multi Cap Fund Direct - Growth | 60000 | 0.14% | 0.14% | 0.14% | May 2025 | |
| Invesco India Large & Mid Cap Fund Direct-Growth | 2197842 | 3.40% | -0.08% | -0.26% | May 2025 |
About Max Healthcare Institute
Max Healthcare Institute Limited is an Indian integrated healthcare provider operating a network of healthcare facilities, primarily in North India. The company offers a range of medical services including primary, secondary, tertiary, and quaternary care across various specialties. It operates 17 healthcare facilities in Delhi NCR, Haryana, Punjab, Uttarakhand, and Maharashtra. Max Healthcare has two strategic business units: Max Lab, which provides diagnostic services outside its hospital network, and Max@Home, offering health and wellness services at home. The company is listed on the BSE and NSE, with Mr. Abhay Soi and Kayak Investments Holding Pte. Ltd. as its current promoters.
Website
Chairperson NameAbhay Soi
we are part of Raise Financial Services
built with love
for indians who love to invest & trade
Market Community
Follow us on
